metformin or semaglutide for weight loss vs. Ozempic: Which Drug Loss, Prediabetes, PCOS, and More metformin or semaglutide for weight

Wegovy Side Effects : Nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis

PMID: 39491755

The question of whether GOLO can be safely combined with Wegovy lacks definitive clinical evidence, as no formal studies have examined this specific combination

Given the relatively high level of gross Medicare Part D spending as of 2022 for the two semaglutide products combined, Ozempic and Rybelsus, its possible that Medicare could select this product for drug price negotiation as early as 2025, which would be just over seven years past its earliest FDA approval in late 2017